BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nölting S, Ullrich M, Pietzsch J, Ziegler CG, Eisenhofer G, Grossman A, Pacak K. Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine. Cancers (Basel) 2019;11:E1505. [PMID: 31597347 DOI: 10.3390/cancers11101505] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Lu YT, Fan P, Zhang D, Zhang Y, Meng X, Zhang QY, Zhao L, Yang KQ, Zhou XL. Overview of Monogenic Forms of Hypertension Combined With Hypokalemia. Front Pediatr 2020;8:543309. [PMID: 33569358 DOI: 10.3389/fped.2020.543309] [Reference Citation Analysis]
2 Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K. Personalized management of pheochromocytoma and paraganglioma. Endocr Rev 2021:bnab019. [PMID: 34147030 DOI: 10.1210/endrev/bnab019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Aygun N, Uludag M. Pheochromocytoma and Paraganglioma: From Treatment to Follow-up. Sisli Etfal Hastan Tip Bul 2020;54:391-8. [PMID: 33364876 DOI: 10.14744/SEMB.2020.58998] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Aygun N, Uludag M. Pheochromocytoma and Paraganglioma: From Clinical Findings to Diagnosis. Sisli Etfal Hastan Tip Bul 2020;54:271-80. [PMID: 33312023 DOI: 10.14744/SEMB.2020.14826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Iglesias P, Santacruz E, García-Sancho P, Marengo AP, Guerrero-Pérez F, Pian H, Fajardo C, Villabona C, Díez JJ. Pheochromocytoma: A three-decade clinical experience in a multicenter study. Rev Clin Esp 2020:S0014-2565(20)30114-4. [PMID: 32646754 DOI: 10.1016/j.rce.2019.12.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Katabathina VS, Marji H, Khanna L, Ramani N, Yedururi S, Dasyam A, Menias CO, Prasad SR. Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies. Radiographics 2020;40:1600-26. [PMID: 33001791 DOI: 10.1148/rg.2020200042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Scriba LD, Bornstein SR, Santambrogio A, Mueller G, Huebner A, Hauer J, Schedl A, Wielockx B, Eisenhofer G, Andoniadou CL, Steenblock C. Cancer Stem Cells in Pheochromocytoma and Paraganglioma. Front Endocrinol (Lausanne) 2020;11:79. [PMID: 32158431 DOI: 10.3389/fendo.2020.00079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
8 Zhang H, Ge F, Shui X, Xiang Y, Wang X, Liao C, Wang J. NIX protein enhances antioxidant capacity of and reduces the apoptosis induced by HSP90 inhibitor luminespib/NVP-AUY922 in PC12 cells. Cell Stress Chaperones 2021;26:495-504. [PMID: 33629253 DOI: 10.1007/s12192-021-01193-6] [Reference Citation Analysis]
9 Fuqua JS. Adrenal Tumors in Childhood. Adv Pediatr 2021;68:227-44. [PMID: 34243855 DOI: 10.1016/j.yapd.2021.05.015] [Reference Citation Analysis]
10 Shukla RP, Aroosh M, Matzafi A, Ben‐yoav H. Partially Functional Electrode Modifications for Rapid Detection of Dopamine in Urine. Adv Funct Mater 2021;31:2004146. [DOI: 10.1002/adfm.202004146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Snezhkina A, Pavlov V, Dmitriev A, Melnikova N, Kudryavtseva A. Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas. Life (Basel) 2021;11:1179. [PMID: 34833055 DOI: 10.3390/life11111179] [Reference Citation Analysis]
12 Iglesias P, Santacruz E, García-Sancho P, Marengo AP, Guerrero-Pérez F, Pian H, Fajardo C, Villabona C, Díez JJ. Pheochromocytoma: A three-decade clinical experience in a multicenter study. Rev Clin Esp (Barc) 2021;221:18-25. [PMID: 33998473 DOI: 10.1016/j.rceng.2019.12.011] [Reference Citation Analysis]
13 Kou A, Patel JK, Adetula I, Frunzi J. Gastric Cancer Presenting as Persistent Pneumonia: An Unusual Case Report. Cureus 2021;13:e14024. [PMID: 33889464 DOI: 10.7759/cureus.14024] [Reference Citation Analysis]
14 Jhawar S, Arakawa Y, Kumar S, Varghese D, Kim YS, Roper N, Elloumi F, Pommier Y, Pacak K, Del Rivero J. New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications. Cancers (Basel) 2022;14:594. [PMID: 35158861 DOI: 10.3390/cancers14030594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Casey RT, Valk GD, Schalin-Jäntti C, Grossman AB, Thakker RV. ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs). Eur J Endocrinol 2020;183:G79-88. [PMID: 32554825 DOI: 10.1530/EJE-20-0424] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Talvacchio S, Nazari MA, Pacak K. Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment. Curr Opin Endocrinol Diabetes Obes 2022;29:294-301. [PMID: 35621181 DOI: 10.1097/MED.0000000000000724] [Reference Citation Analysis]
17 Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, Jhaveri A, Ferrarini I, Lee Y, Parker C, Zhang Y, Borsuk R, Chang WI, Honeyman JN, Tavora F, Carneiro B, Raufi A, Huntington K, Carlsen L, Louie A, Safran H, Seyhan AA, Tarapore RS, Schalop L, Stogniew M, Allen JE, Oster W, El-Deiry WS. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. Neoplasia 2020;22:725-44. [PMID: 33142238 DOI: 10.1016/j.neo.2020.09.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
18 Tepede AA, Welch J, Lee M, Mandl A, Agarwal SK, Nilubol N, Patel D, Cochran C, Simonds WF, Weinstein LS, Jha A, Millo C, Pacak K, Blau JE. 18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma. Endocrinol Diabetes Metab Case Rep 2020;2020:EDM190156. [PMID: 32130200 DOI: 10.1530/EDM-19-0156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Pamporaki C, Prodanov T, Meuter L, Berends AM, Bechmann N, Constantinescu G, Beuschlein F, Remde H, Januszewicz A, Kerstens MN, Timmers HJ, Taïeb D, Robledo M, Lenders JW, Pacak K, Eisenhofer G. Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma. European Journal of Cancer 2022;169:32-41. [DOI: 10.1016/j.ejca.2022.03.032] [Reference Citation Analysis]
20 Uher O, Huynh TT, Zhu B, Horn LA, Caisova V, Hadrava Vanova K, Medina R, Wang H, Palena C, Chmelar J, Zhuang Z, Zenka J, Pacak K. Identification of Immune Cell Infiltration in Murine Pheochromocytoma during Combined Mannan-BAM, TLR Ligand, and Anti-CD40 Antibody-Based Immunotherapy. Cancers (Basel) 2021;13:3942. [PMID: 34439097 DOI: 10.3390/cancers13163942] [Reference Citation Analysis]
21 Vit O, Patel M, Musil Z, Hartmann I, Frysak Z, Miettinen M, Pacak K, Petrak J. Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity. Molecules 2021;26:6567. [PMID: 34770976 DOI: 10.3390/molecules26216567] [Reference Citation Analysis]
22 Patel JK, Reddy V, Stepman G, Angelo D, Frunzi J. Pheochromocytoma Presenting as Testicular Pain: An Unusual Case Report. Case Rep Endocrinol 2021;2021:6699409. [PMID: 33953991 DOI: 10.1155/2021/6699409] [Reference Citation Analysis]
23 Winzeler B, Challis BG, Casey RT. Precision Medicine in Phaeochromocytoma and Paraganglioma. J Pers Med 2021;11:1239. [PMID: 34834591 DOI: 10.3390/jpm11111239] [Reference Citation Analysis]
24 Prado-wohlwend S. Functional imaging studies of the adrenal cortex. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2020;39:393-403. [DOI: 10.1016/j.remnie.2020.10.006] [Reference Citation Analysis]
25 Seo SH, Kim JH, Kim MJ, Cho SI, Kim SJ, Kang H, Shin CS, Park SS, Lee KE, Seong MW. Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma. Endocrinol Metab (Seoul) 2020;35:909-17. [PMID: 33397043 DOI: 10.3803/EnM.2020.756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Abib SCV, Weldon CB. Management of Adrenal Tumors in Pediatric Patients. Surg Oncol Clin N Am 2021;30:275-90. [PMID: 33706900 DOI: 10.1016/j.soc.2020.11.012] [Reference Citation Analysis]
27 Ryder SJ, Love AJ, Duncan EL, Pattison DA. PET detectives: Molecular imaging for phaeochromocytomas and paragangliomas in the genomics era. Clin Endocrinol (Oxf) 2021;95:13-28. [PMID: 33296100 DOI: 10.1111/cen.14375] [Reference Citation Analysis]
28 Seger C, Salzmann L. After another decade: LC-MS/MS became routine in clinical diagnostics. Clin Biochem 2020;82:2-11. [PMID: 32188572 DOI: 10.1016/j.clinbiochem.2020.03.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
29 Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers HJLM, Castinetti F, Dralle H, Widimský J, Gimenez-Roqueplo AP, Eisenhofer G. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 2020;38:1443-56. [PMID: 32412940 DOI: 10.1097/HJH.0000000000002438] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 26.0] [Reference Citation Analysis]
30 Gläsker S, Vergauwen E, Koch CA, Kutikov A, Vortmeyer AO. Von Hippel-Lindau Disease: Current Challenges and Future Prospects. Onco Targets Ther 2020;13:5669-90. [PMID: 32606780 DOI: 10.2147/OTT.S190753] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
31 Hiromasa T, Wakabayashi H, Kayano D, Inaki A, Watanabe S, Mori H, Akatani N, Yamase T, Kunita Y, Saito S, Kinuya S. Prognostic factors for refractory pheochromocytoma and paraganglioma after 131I-metaiodobenzylguanidine therapy. Ann Nucl Med 2021. [PMID: 34647244 DOI: 10.1007/s12149-021-01685-6] [Reference Citation Analysis]
32 Remde H, Nölting S. [Pheochromocytoma - Disease Model for Personalized Medicine]. Dtsch Med Wochenschr 2021;146:1520-6. [PMID: 34826837 DOI: 10.1055/a-1240-9835] [Reference Citation Analysis]
33 Brandt F, Ullrich M, Laube M, Kopka K, Bachmann M, Löser R, Pietzsch J, Pietzsch HJ, van den Hoff J, Wodtke R. "Clickable" Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals. J Med Chem 2021. [PMID: 34939412 DOI: 10.1021/acs.jmedchem.1c01791] [Reference Citation Analysis]
34 Mohr H, Foscarini A, Steiger K, Ballke S, Rischpler C, Schilling F, Pellegata NS. Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment. EJNMMI Res 2021;11:121. [PMID: 34894301 DOI: 10.1186/s13550-021-00855-x] [Reference Citation Analysis]
35 Pozza C, Sesti F, Di Dato C, Sbardella E, Pofi R, Schiavi F, Bonifacio V, Isidori AM, Faggiano A, Lenzi A, Giannetta E. A Novel MAX Gene Mutation Variant in a Patient With Multiple and "Composite" Neuroendocrine-Neuroblastic Tumors. Front Endocrinol (Lausanne) 2020;11:234. [PMID: 32508744 DOI: 10.3389/fendo.2020.00234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
36 Platzer P, Espinosa Ginic MA, Potenziani Pradella S. The Heart of the Issue: A Case Report of Recurrent Reversible Stress-Induced Cardiomyopathy. Am J Case Rep 2020;21:e924876. [PMID: 32620739 DOI: 10.12659/AJCR.924876] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Yamazaki Y, Gao X, Pecori A, Nakamura Y, Tezuka Y, Omata K, Ono Y, Morimoto R, Satoh F, Sasano H. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients. Front Endocrinol (Lausanne) 2020;11:587769. [PMID: 33193100 DOI: 10.3389/fendo.2020.587769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Martinelli S, Maggi M, Rapizzi E. Pheochromocytoma/paraganglioma preclinical models: which to use and why? Endocr Connect 2020;9:R251-60. [PMID: 33252357 DOI: 10.1530/EC-20-0472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Stojanoski S, Boldt HB, Kozic D, Patócs A, Korbonits M, Medic-Stojanoska M, Casar-Borota O. Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features. Front Oncol 2021;11:739255. [PMID: 34888235 DOI: 10.3389/fonc.2021.739255] [Reference Citation Analysis]
40 Yadav MP, Ballal S, Sahoo RK, Bal C. Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study. Eur J Nucl Med Mol Imaging 2021. [PMID: 34837103 DOI: 10.1007/s00259-021-05632-5] [Reference Citation Analysis]
41 Ilanchezhian M, Jha A, Pacak K, Del Rivero J. Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma. Curr Treat Options Oncol 2020;21:85. [PMID: 32862332 DOI: 10.1007/s11864-020-00787-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
42 Farquhar HE, Wong M, Puri G, Sinha A. A SERIES OF TWO PATIENTS WITH CARDIAC PARAGANGLIOMAS. AACE Clin Case Rep 2020;6:e174-8. [PMID: 32671219 DOI: 10.4158/ACCR-2019-0437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Furnica RM, Dusoruth MM, Persu A, Gruson D, Mourad M, Maiter D. Influence of secretory phenotype and preoperative preparation on surgical outcome in pheochromocytoma. Endocr Connect 2021;10:92-101. [PMID: 33320109 DOI: 10.1530/EC-20-0537] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Smith JD, Bellile EL, Else T, Basura G. Head and Neck Paragangliomas: Patterns of Otolaryngology Referrals for Genetic Testing Over 2 Decades. OTO Open 2021;5:2473974X21995453. [PMID: 33748650 DOI: 10.1177/2473974X21995453] [Reference Citation Analysis]
45 Gao S, Liu L, Li Z, Pang Y, Shi J, Zhu F. Seven Novel Genes Related to Cell Proliferation and Migration of VHL-Mutated Pheochromocytoma. Front Endocrinol (Lausanne) 2021;12:598656. [PMID: 33828526 DOI: 10.3389/fendo.2021.598656] [Reference Citation Analysis]
46 Prado-wohlwend S, del Olmo-garcía MI, Bello-arques P, Merino-torres JF. [177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center. Front Endocrinol 2022;13:778322. [DOI: 10.3389/fendo.2022.778322] [Reference Citation Analysis]
47 Patel M, Tena I, Jha A, Taieb D, Pacak K. Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World. Front Endocrinol (Lausanne) 2021;12:625312. [PMID: 33854479 DOI: 10.3389/fendo.2021.625312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Aygun N, Uludag M. Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings. Sisli Etfal Hastan Tip Bul 2020;54:159-68. [PMID: 32617052 DOI: 10.14744/SEMB.2020.18794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
49 Jehangir W, Karabachev A, Tsao J, Anker CJ, Garapati SS, Kikut JK, Rehman HT. Metastatic Malignant Paraganglioma Presenting as a Neck Mass Treated with Radiolabeled Somatostatin Analog. Case Rep Oncol Med 2021;2021:8856167. [PMID: 34211793 DOI: 10.1155/2021/8856167] [Reference Citation Analysis]